| Item Type | Name |
|
Academic Article
|
Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment.
|
|
Academic Article
|
Effects of Lifetime Occupational Pesticide Exposure on Postural Control Among Farmworkers and Non-Farmworkers.
|
|
Academic Article
|
Update in asthma 2006.
|
|
Academic Article
|
Hydrofluoroalkane mandate in effect January 1, 2009: Switch from chlorofluorocarbon- to hydrofluoroalkane-propelled inhalers requires active transition.
|
|
Academic Article
|
Regulatory haplotypes in ARG1 are associated with altered bronchodilator response.
|
|
Academic Article
|
A trial of clarithromycin for the treatment of suboptimally controlled asthma.
|
|
Academic Article
|
IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor a antagonist.
|
|
Academic Article
|
Differential expression of TRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: evidence for a role of TRAIL in eosinophil survival.
|
|
Academic Article
|
beta-Adrenergic receptor polymorphisms and response to salmeterol.
|
|
Academic Article
|
Novel and emerging therapies for asthma.
|
|
Academic Article
|
Sequence analysis of HSPA1A and HSPA1B in a multi-ethnic study population.
|
|
Academic Article
|
Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients.
|
|
Academic Article
|
Beta-2 adrenergic agonists: focus on safety and benefits versus risks.
|
|
Academic Article
|
Impact of race on asthma treatment failures in the asthma clinical research network.
|
|
Academic Article
|
The IL6R variation Asp(358)Ala is a potential modifier of lung function in subjects with asthma.
|
|
Concept
|
Caspase 8
|
|
Concept
|
Survival Rate
|
|
Concept
|
MAP Kinase Signaling System
|
|
Concept
|
Interferon Regulatory Factor-2
|
|
Concept
|
Humans
|
|
Concept
|
Interleukin-4 Receptor alpha Subunit
|
|
Concept
|
Chromosomes, Human, Pair 12
|
|
Concept
|
Cell Movement
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Cataract
|
|
Concept
|
CpG Islands
|
|
Concept
|
Membrane Glycoproteins
|
|
Concept
|
Hydrocarbons, Fluorinated
|
|
Concept
|
Antibodies, Anti-Idiotypic
|
|
Concept
|
Fibrinogen
|
|
Concept
|
Liver Cirrhosis
|
|
Concept
|
Interleukin-1
|
|
Concept
|
Brain Death
|
|
Concept
|
Thrombospondins
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Rhinitis, Allergic, Perennial
|
|
Concept
|
Zinc Fingers
|
|
Concept
|
Oxytocics
|
|
Concept
|
Medication Adherence
|
|
Concept
|
Odds Ratio
|
|
Concept
|
STAT4 Transcription Factor
|
|
Concept
|
Caspases
|
|
Concept
|
Leukotriene Antagonists
|
|
Concept
|
Inflammation
|
|
Concept
|
London
|
|
Concept
|
Ionophores
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Receptors, Interleukin-6
|
|
Concept
|
Tobacco Smoke Pollution
|
|
Concept
|
Liver Transplantation
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
Glaucoma
|
|
Concept
|
Immunoglobulin E
|
|
Concept
|
Sleep
|
|
Concept
|
Protease Inhibitors
|
|
Concept
|
Hypersensitivity, Immediate
|
|
Concept
|
Lymphocyte Activation
|
|
Concept
|
Platelet Aggregation Inhibitors
|
|
Concept
|
Preoperative Care
|
|
Concept
|
Metabolomics
|
|
Concept
|
Medicare
|
|
Concept
|
Health Maintenance Organizations
|
|
Concept
|
Shewanella putrefaciens
|
|
Concept
|
Receptors, Tumor Necrosis Factor, Type I
|
|
Concept
|
Allergens
|
|
Concept
|
Th1 Cells
|
|
Concept
|
ABO Blood-Group System
|
|
Concept
|
Macrolides
|
|
Concept
|
Arginine
|
|
Concept
|
Corynebacterium
|
|
Concept
|
Research Design
|
|
Concept
|
Animals
|
|
Concept
|
Chi-Square Distribution
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
|
Concept
|
Disease Susceptibility
|
|
Concept
|
Phosphodiesterase Inhibitors
|
|
Concept
|
Chronic Disease
|
|
Concept
|
Adrenergic beta-Antagonists
|
|
Concept
|
African Continental Ancestry Group
|
|
Concept
|
New Jersey
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Ovarian Neoplasms
|
|
Concept
|
Patient Education as Topic
|
|
Concept
|
Immunophenotyping
|
|
Concept
|
Bronchodilator Agents
|
|
Concept
|
Transforming Growth Factors
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Natriuretic Peptide, Brain
|
|
Concept
|
Aspirin
|
|
Concept
|
Sample Size
|
|
Concept
|
Methacholine Chloride
|
|
Concept
|
Chromosomes, Human, Pair 4
|
|
Concept
|
Acute Disease
|
|
Concept
|
Skin Tests
|
|
Concept
|
Isoleucine
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Tumor Necrosis Factor Decoy Receptors
|
|
Concept
|
C-Reactive Protein
|
|
Concept
|
Interleukin-4
|
|
Concept
|
Chromosomes, Human, Pair 10
|
|
Concept
|
Regression Analysis
|
|
Concept
|
Bronchoalveolar Lavage
|
|
Concept
|
Hydrocortisone
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Disease Management
|
|
Concept
|
T-Lymphocyte Subsets
|
|
Concept
|
Observer Variation
|
|
Concept
|
Dietary Supplements
|
|
Concept
|
Leukocyte Count
|
|
Concept
|
National Heart, Lung, and Blood Institute (U.S.)
|
|
Concept
|
Obesity
|
|
Concept
|
Logistic Models
|
|
Concept
|
Carcinogens
|
|
Concept
|
Interleukin-5
|
|
Concept
|
Mice
|
|
Concept
|
Kv Channel-Interacting Proteins
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Ocular Hypertension
|
|
Concept
|
Chromosomes, Human, Pair 6
|
|
Concept
|
DNA Primers
|
|
Concept
|
Preferred Provider Organizations
|
|
Concept
|
Soft Tissue Infections
|
|
Concept
|
Linear Models
|
|
Concept
|
Receptors, Tumor Necrosis Factor, Type II
|
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
|
Concept
|
Hypersensitivity
|
|
Concept
|
Receptors, Muscarinic
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Albuterol
|
|
Concept
|
Dinoprostone
|
|
Concept
|
Glutathione Peroxidase
|
|
Concept
|
Immune Sera
|
|
Concept
|
Tryptophan
|
|
Concept
|
HLA-DQ Antigens
|
|
Concept
|
Receptors, Adrenergic, beta
|
|
Concept
|
Treatment Failure
|
|
Concept
|
HLA-DR Antigens
|
|
Concept
|
Insurance Claim Review
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Anti-Inflammatory Agents
|
|
Concept
|
Leukotrienes
|
|
Concept
|
Uncertainty
|
|
Concept
|
Asian Continental Ancestry Group
|
|
Concept
|
Bronchoalveolar Lavage Fluid
|
|
Concept
|
Models, Statistical
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Myofibrils
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Tetradecanoylphorbol Acetate
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Aerosol Propellants
|
|
Concept
|
Hospitalization
|
|
Concept
|
Interleukin-2
|
|
Concept
|
Respiratory Tract Infections
|
|
Concept
|
Moraxella
|
|
Concept
|
Tosyl Compounds
|
|
Concept
|
Linkage Disequilibrium
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Cytokines
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Mucin-5B
|
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
|
Concept
|
Neutrophils
|
|
Concept
|
Nutrition Surveys
|
|
Concept
|
Receptors, Adrenergic, beta-2
|
|
Concept
|
Health Surveys
|
|
Concept
|
Leukotriene D4
|
|
Concept
|
beta Karyopherins
|
|
Concept
|
Anti-Bacterial Agents
|
|
Concept
|
Muscarinic Antagonists
|
|
Concept
|
Patient Selection
|
|
Concept
|
Postural Balance
|
|
Concept
|
Motor Activity
|
|
Concept
|
Emphysema
|
|
Concept
|
Heat-Shock Proteins
|
|
Concept
|
Interferon-gamma
|
|
Concept
|
Caspase 9
|
|
Concept
|
Adrenergic beta-Agonists
|
|
Concept
|
Androstadienes
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Pain
|
|
Concept
|
Vitamin D Deficiency
|
|
Concept
|
Incidence
|
|
Concept
|
Dermatitis, Atopic
|
|
Concept
|
Inspiratory Capacity
|
|
Concept
|
Recurrence
|
|
Concept
|
Cell Division
|
|
Concept
|
Interleukin-13
|
|
Concept
|
p38 Mitogen-Activated Protein Kinases
|
|
Concept
|
Cross-Over Studies
|
|
Concept
|
Actins
|
|
Concept
|
Sex Distribution
|
|
Concept
|
Patient Care Team
|
|
Concept
|
Nitric Oxide
|
|
Concept
|
Paranasal Sinuses
|
|
Concept
|
Polymorphism, Single Nucleotide
|
|
Concept
|
Fluorescent Antibody Technique
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Disease Progression
|
|
Concept
|
Pharmacogenetics
|
|
Concept
|
Lymphocyte Count
|
|
Concept
|
Influenza A Virus, H1N1 Subtype
|
|
Concept
|
Anti-Asthmatic Agents
|
|
Concept
|
Receptors, Leukotriene
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Cell Adhesion Molecules
|
|
Concept
|
Anti-Allergic Agents
|
|
Concept
|
Receptors, Cell Surface
|
|
Concept
|
North Carolina
|
|
Concept
|
Single-Blind Method
|
|
Concept
|
HSP70 Heat-Shock Proteins
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Internet
|
|
Concept
|
Controlled Clinical Trials as Topic
|
|
Concept
|
National Institutes of Health (U.S.)
|
|
Concept
|
Azithromycin
|
|
Concept
|
Prevalence
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Patient Compliance
|
|
Concept
|
Eosinophilia
|
|
Concept
|
Patient Preference
|
|
Concept
|
Palliative Care
|
|
Concept
|
Microfilament Proteins
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Mycoplasma pneumoniae
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Cholinergic Antagonists
|
|
Concept
|
Chlorofluorocarbons
|
|
Concept
|
Leptin
|
|
Concept
|
3' Untranslated Regions
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
African Americans
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Idiopathic Pulmonary Fibrosis
|
|
Concept
|
Intra-Abdominal Fat
|
|
Concept
|
Infant, Newborn
|
|
Concept
|
Oligodeoxyribonucleotides
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
Fatty Liver
|
|
Concept
|
Interleukin-12
|
|
Concept
|
Microsomes
|
|
Concept
|
Th2 Cells
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Nose
|
|
Concept
|
Glucocorticoids
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
Lymphatic Metastasis
|
|
Concept
|
Receptors, Notch
|
|
Concept
|
Clarithromycin
|
|
Concept
|
Polymerase Chain Reaction
|
|
Concept
|
United States
|
|
Concept
|
Probability
|
|
Concept
|
Administration, Inhalation
|
|
Concept
|
Vaccination
|
|
Concept
|
Cholecalciferol
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Delivery of Health Care
|
|
Concept
|
Receptors, Tumor Necrosis Factor
|
|
Concept
|
Asthma
|
|
Concept
|
European Continental Ancestry Group
|
|
Concept
|
Risk
|
|
Concept
|
Risk Factors
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Patient Readmission
|
|
Concept
|
Receptors, TNF-Related Apoptosis-Inducing Ligand
|
|
Concept
|
Nasal Polyps
|
|
Concept
|
Vitamins
|
|
Concept
|
Base Sequence
|
|
Concept
|
Airway Resistance
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Killer Cells, Natural
|
|
Concept
|
Bronchoconstrictor Agents
|
|
Concept
|
ROC Curve
|
|
Concept
|
Insurance, Health, Reimbursement
|
|
Concept
|
Cyclooxygenase 1
|
|
Concept
|
Respiratory Mucosa
|
|
Concept
|
Discriminant Analysis
|
|
Concept
|
Lymphocyte Subsets
|
|
Concept
|
TNF-Related Apoptosis-Inducing Ligand
|
|
Concept
|
Protein Array Analysis
|
|
Concept
|
Mouth Mucosa
|
|
Concept
|
Cell Count
|
|
Concept
|
Adenocarcinoma, Papillary
|
|
Academic Article
|
Periaortic pancreatic rests: a case report.
|
|
Academic Article
|
Heterogeneity in the pathology and treatment of asthma.
|
|
Academic Article
|
The risks, benefits, and uncertainties of stepping down asthma medications.
|
|
Academic Article
|
Impact of Age and Sex on Response to Asthma Therapy.
|
|
Academic Article
|
Effects of bronchoscopy on lung function in asthmatics.
|
|
Grant
|
Asthma Clinical Research Network (ACRN)
|
|
Academic Article
|
Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age.
|
|
Academic Article
|
New and Anticipated Therapies for Severe Asthma.
|
|
Academic Article
|
Effects of endogenous sex hormones on lung function and symptom control in adolescents with asthma.
|
|
Academic Article
|
Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study.
|
|
Academic Article
|
Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.
|